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The immune system is complex and pervasive as it functions to prevent or limit infections
in the human body. In a healthy organism, the immune system and the redox balance of
immune cells maintain homeostasis within the body. The failure to maintain the balance
may lead to impaired immune response and either over activity or abnormally low activity
of the immune cells resulting in autoimmune or immune deficiency diseases. Compounds
containing α,β-unsaturated carbonyl-based moieties are often reactive. The reactivity
of these groups is responsible for their diverse pharmacological activities, and the
most important and widely studied include the natural compounds curcumin, chalcone,
and zerumbone. Numerous studies have revealed the mainly immunosuppressive and
anti-inflammatory activities of the aforesaid compounds. This review highlights the
specific immunosuppressive effects of these natural α,β-unsaturated carbonyl-based
compounds, and their analogs and derivatives on different types of immune cells of
the innate (granulocytes, monocytes, macrophages, and dendritic cells) and adaptive
(T cells, B cells, and natural killer cells) immune systems. The inhibitory effects of
these compounds have been comprehensively studied on neutrophils, monocytes and
macrophages but their effects on T cells, B cells, natural killer cells, and dendritic cells
have not been well investigated. It is of paramount importance to continue generating
experimental data on the mechanisms of action of α,β-unsaturated carbonyl-based
compounds on immune cells to provide useful information for ensuing research to
discover new immunomodulating agents.
Keywords: α, β-unsaturated carbonyl-based compounds, curcumin, chalcone, zerumbone, immune cells,
immunosuppressive effects
INTRODUCTION
The immune system is the body’s complex and pervasive defense system which maintained the
integrity of the body and protects it from microbial invasion. It refers to organization of immune
cells and specialized immune molecules that have evolved to mediate resistance to infections.
The immune system can be categorized into two major divisions i.e., innate immune system and
adaptive immune system. The innate immune system refers to non-specific immunity as it is
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destined to attack any foreign particle invading the body and
hence serve as primary defense for the body. Neutrophils,
macrophages, and dendritic cells are the central players of innate
immunity. Contrary to this, adaptive or acquired immunity
produces a specific effect in response to an antigen and reserves
the feature of immunological memory that distinguishes it
from the aforementioned response. The members of acquired
immunity involve majorly T cells and B cells (Lee et al., 2015).
In healthy organism, the immune system and the adequate
redox balance of immune cells maintain homeostasis within
the body. The failure to maintain the balance may lead to
impaired immune response and hence an abnormal immune
system (Ilangkovan et al., 2015). Most of the immune system
disorders cause abnormally low activity or over activity of
the immune cells. In cases of immune system over activity,
the body attacks and damages its own tissues referring to
acquired immune system reaction (autoimmune diseases) while
immune deficiency diseases decrease the body’s ability to fight
invaders, causing vulnerability to infections. Among the most
common diseases are rheumatoid arthritis, type1 diabetes,
systemic lupus erythematosus, tuberculosis, and atherogenesis.
The autoimmune destruction of the pancreatic β cells within the
islets of Langerhans results in the progression of type 1 diabetes
(Mehrotra et al., 2013).
The word immunomodulation circles around the concept
of reorganizing the immune system to achieve the therapeutic
benefit. The aim of immunomodulators or immunotherapy
is to modify the immune response according to pathological
condition. Generally, there are two clinical situations when
the immune system are required to be managed i.e., when the
immune response is abnormally decreased (immunodeficiency)
e.g., cancer, hepatitis, HIV and tuberculosis or increased
like diabetes, arthritis, lupus, eczema, and multiple sclerosis
(autoimmunity). In case of immunodeficiency, a therapy
that particularly boosts up the immune response called
immunostimulants is desired while immunosuppressant
abolished the overactive immune system. Augmentation of the
immune response is desirable to prevent infection in states of
immunodeficiency or in case of overactive immune system.
Immunoadjuvants is another term used nowadays, are specific
immune stimulators which enhance the efficacy of vaccine
(Gea-Banacloche, 2006). Over many decades, many natural,
Abbreviations: APC, antigen presenting cells; NF-κB, nuclear factor kappa B;
TNFα, tumor necrosis factor alpha; ROS, reactive oxygen species; IL, interleukin;
PBMCs, peripheral blood mononuclear cells; PMNCs, polymorphonuclear cells;
fMLP, N-Formylmethionine-leucyl-phenylalanine; PKC, protein kinase C; ICAM-
1, Intercellular Adhesion Molecule 1; VCAM-1,Vascular cell adhesion protein
1; CINC, cytokine induced neutrophil chemoattractant, OVA, ovalbumin; iNOS
inducible nitric oxide synthase; NO, nitric oxide; LTB4, leukotriene B4; PMA,
phorbol 12-myristate 13-acetate; LPS, lipopolysaccharide; UVB, ultraviolet-B;
BALF, bronchoalveolar lavage fluid CON A, concanavalin A; ERK, extracellular
signal-regulated kinases; MCP-1, Monocyte chemoattractant protein-1; MIP-
1β, Macrophage Inflammatory Protein 1-beta; CCR5, chemokine receptor 5;
AChE, acetylcholinesterase; PLA2, phospholipase A2; PGE2, prostaglandin E2;
COX 2, cyclooxygenase 2, LOX, lipoxygenase; IFN-γ, interferon gamma; AP-1,
activated protein 1; TLR, toll like receptors; DCs dendritic cells; MHC, major
histocompatibility complex; PHA, Phytohaemagglutinin; STAT, Signal transducer
and activator of transcription 3; LAK, lymphokine activated killer cells.
or synthetic immunomodulators are being used for managing
immune disorders. This review is to provide updated overview
of specific immunomodulatory effects of the most important
and widely studied natural products containing α,β-unsaturated
carbonyls, i.e., curcumin (1), chalcone (2), and zerumbone (3).
The activities of these natural products and their analogs and
derivatives on different types of immune cells of the innate and
adaptive immune systems have been comprehensively discussed.
NATURAL α,β-UNSATURATED
CARBONYL-BASED COMPOUNDS
α,β-Unsaturated carbonyl-based compounds refers to such
structures possessing α,β-carbonyl moieties. In such compounds
the carbon-carbon double bond and carbon-oxygen double
bond are segregated by only one carbon-carbon single bond
i.e., double bonds are conjugated. These conjugations not
only give the properties of the functional group attached but
also give some other properties to the compounds. Figure 1
illustrates the general structure of α,β-unsaturated carbonyl-
based compounds. These compounds are considered to be the
most reactive substructures of natural products or synthetic
molecules. The reactivity of these groups owes a diverse array
of pharmacological activities. The most important and widely
studied α,β-unsaturated carbonyl-based compounds include the
natural products, curcumin (1), zerumbone (2), chalcone (3),
and their analogs and derivatives. The structures of curcumin,
chalcone, and zerumbone are shown in Figure 2. In fact one-sixth
of the currently known natural products contain these potentially
reactive substructures (Rodrigues et al., 2016).
Curcumin (1), the active principle of turmeric, is a
hydrophobic polyphenol mainly isolated from the rhizomes
(turmeric) of Curcuma longa (Anand et al., 2008). Chemically,
it is a bis-α,β-unsaturated β-diketone composed of two aromatic
rings joined together by two carbonyl groups. Despite the fact
that curcumin is a multi-targeting agent and safer at higher doses,
poor bioavailability, and solubility is still a point at issue for
FIGURE 1 | General structure of α,β-unsaturated carbonyl-based
compounds.
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FIGURE 2 | Chemical structures of natural α,β-unsaturated carbonyl-based compounds.
the researchers. To overcome this problem, scientists adopted
a number of strategies including formulation of curcumin with
adjuvant like piperine, curcumin-based drug delivery system,
and structural modification of curcumin (Anand et al., 2007).
These approaches have not yet achieved the desired therapeutic
purpose but somewhat improved the pharmacokinetic profile
of curcumin. The curcumin analogs were synthesized in a
number of different ways either preserving the β-diketonemoiety
or removing it. Previous studies reported different laboratory
methods involving multiple types of catalysts for the synthesis
of curcumin-like structures but the most common method was
found to be a Claisen–Schmidt condensation reaction, between
a ketone and aldehyde in the presence of a polar solvent (Anand
et al., 2008).
Zerumbone (2), (2E,6E,10E)-2,6,9,9-tetramethylcycloundeca-
2,6,10-trien-1-one, a crystalline monocyclic sesquiterpene, is
mainly isolated from the rhizomes of shampoo ginger (Zingiber
zerumbet). Zerumbone was isolated for the first time in 1960
and structurally elucidated in 1965 (Dev, 1960; Damodaran
and Dev, 1965). It contains α,β-unsaturated carbonyl moiety
along with 3 double bonds, one at C-2 and the rest at C-
6 and C-9 positions. Chalcone (3) is a member of flavonoid
family with a 1, 3-diphenyl-2-propen-1-one skeleton. Analogous
to curcumin, the structure of chalcone consists of two aromatic
rings linked by a three carbon α,β-unsaturated carbonyl system.
Chalcone and chalcone-based derivatives can be obtained using
variety of laboratory methods and schemes. Numerous lines of
evidence suggest that acid or base catalyzed aldol condensation or
Claisen–Schmidt condensation of acetophenones with aromatic
aldehydes are among the most conventional methods (Datta
et al., 1971; Makrandi and Kumar, 2004).
Previous studies have indicated that these natural α,β-
unsaturated carbonyl compounds and their analogs and
derivatives exhibited a wide range of biological activities. A
number of studies have showed that zerumbone, chalcone
derivatives and curcumin analogs exerted immunomodulatory
role (Feng et al., 2005; Magerramov et al., 2006; Keong et al.,
2010; Bukhari et al., 2012, 2013b, 2014a; Lal et al., 2012).
Likewise, antioxidant, anti-inflammatory, antiviral, antibacterial,
antifungal, and antitubercular activities have been exhibited by
these compounds (Lin et al., 2002; Murakami et al., 2002, 2004;
Batovska et al., 2007; Sivakumar et al., 2007; Tomar et al., 2007;
Trivedi et al., 2007; Chiaradia et al., 2008; Chien et al., 2008;
Sulaiman et al., 2010; Jantan et al., 2012; Du et al., 2013; Ou
et al., 2013; Bukhari et al., 2013a; Ahmad et al., 2014; Chen et al.,
2014; Goodarzi et al., 2014). Recently, some studies reported that
α,β-unsaturated moiety displayed acetylcholine esterase (AChE)
and butylcholine esterase (BuChE) inhibition and may serve as
promising agent in the treatment of alzeihmer’s disease (Bag
et al., 2013; Silva et al., 2013; Bukhari et al., 2014b). In addition,
the ketone functional group of these compounds is believed to
possess anticancer potential (Sahu et al., 2012; Bukhari et al.,
2014c; Qin et al., 2016).
Recently, Rodrigues et al. (2016) suggested that compounds
containing α,β-unsaturated carbonyls may not serve as good
leads for drug design because of their potential to undergo
Michael addition reaction leading to unwanted side effects, such
as cytotoxicity and cell-damage. However, direct interaction
of the groups with enzymes can be desirable. For example
these compounds with Michael-accepting features can block
carcinogenesis by inducing certain enzymes such as glutathione
S-transferase and quinone reductase activity, which inhibits
the reactive electrophilic forms of carcinogens. α,β-Unsaturated
carbonyls may also be desirable moieties as they also have the
ability to be radical scavengers through covalent ligand binding
to target proteins or act as antioxidants, for example by thiol
trapping.
IMMUNOSUPPRESSION OF NATURAL
α,β-UNSATURATED CARBONYL-BASED
COMPOUNDS ON THE INNATE IMMUNE
SYSTEM
Curcumin and its analogs have been shown to be able to arrest
lymphocytes and antigen presenting cells (APC) in autoimmune
diseases (Bright, 2007). As evident in arthritis, they seemed to
inhibit neutrophil activation and subsequent reactive oxygen
species (ROS) production along with suppression of nuclear
factor kappa B (NF-κB) and other inflammatory cytokines
released by white blood cells (Jackson et al., 2006; Jancˇinová
et al., 2009). In a similar manner, curcumin exerted antioxidant
effect, reducing hyperglycemia and also inhibited macrophages-
mediated tumor necrosis factor (TNF) and interleukin-6 (IL-6)
release, activated by dying or stressed B cells (Raine, 1990;
Maradana et al., 2013). Moreover, it was identified that the
increased number of CD8+ T cells has been reduced by the use
of curcumin (Aggarwal and Harikumar, 2009). Correspondingly,
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chalcone and its derivatives have been recognized as exhibiting
therapeutic potential in immune diseases by targeting NF-κB
signaling pathway, kinase activities and others assumed to be
involved in cancer, diabetes, inflammatory diseases, and certain
infections (Zhou and Xing, 2015). Zerumbone found to possess
significant effects on immune system through controlling the
regulation of cytokines and chemokines secretion in immune
cells (Keong et al., 2010; Shieh et al., 2015). Table 1 summarizes
the effects of α,β unsaturated carbonyl-based compounds
on immune cells. The chemical structures of natural α,β-
unsaturated carbonyl-based compounds, and their analogs and
derivatives which exhibited strong immunomodulatory effects on
granulocytes (compounds 4–32), monocytes, and macrophages
(compounds 33–71), and dendritic cells (compounds 72–74) are
shown in Figures 3–5, respectively.
Immunosuppressive Effects of Curcumin
on Granulocytes
Numerous lines of evidence suggest that curcumin may
abate the neutrophil mediated inflammatory responses by
varying different aspects of neutrophil function. Curcumin
treatment inhibited zymosan and n-formyl-methionine-leucyl-
phenylalanine (fMLP)-activated monkey neutrophils. It also
suppressed the production of oxygen free radicals induced by
arachidonic acid (Srivastava, 1989). The reduced production
of oxygen free radicals by curcumin treatment may play an
important role in rheumatoid arthritis. Jancˇinová et al. (2009)
reported that curcumin inhibited the raised level of protein
kinase C (PKC) isozymes by neutrophils in adjuvant induced
arthritis. In the same way, curcumin inhibited the inflammatory
processes initiated by crystal-induced neutrophil activation in a
rheumatoid arthritis model (Jackson et al., 2006). The inhibition
of transmigration and recruitment of neutrophils from blood
vessels to the underlying liver tissue by curcumin has also
been investigated in septic shock. The authors correlated the
reduction of neutrophil’s infiltration to the blocked expression
of intercellular adhesion molecule 1(ICAM-1) and vascular
cell adhesion protein 1 (VCAM-1) in the liver tissue with
curcumin treatment (Madan and Ghosh, 2003). In another
study, curcumin mediated inhibition of neutrophil’s chemotaxis
in a dose-dependent manner. It was reported that curcumin
successfully impeded IL-8 (strong neutrophil chemoattractant)
produced by monocytes and macrophage and also blocked IL-8
induced signal transduction pathway in neutrophils (Takahashi
et al., 2007). Curcumin also reduced the level of cytokine-
induced neutrophil chemoattractant (CINC) in acute lung injury.
Based on the results, it was evidenced that curcumin exhibited
anti-inflammatory activity by dampening CINC protein levels,
which is similar in properties to human cytokine IL-8 and by
diminishing the myeloperoxidase activity, a marker for damage
and deterioration in lung tissues (Lian et al., 2006).
A study on the effect of curcumin on eosinophils in
a murine model of asthma has shown that it inhibited
the ovalbumin-(OVA) induced airway inflammation by three
different mechanisms i.e., by suppressing the expression of
inducible nitric oxide synthase (iNOS) and NO (nitric oxide)
production responsible for significant lung tissue detriment; by
hampering the recruitment of eosinophils and inflammatory cells
that leads to the inflammation of airways; and by repressing
the levels of IL-4 and IL-5 in broncho alveolar lavage fluid
(Moon et al., 2008). In a model of cutaneous anaphylaxis, the
antiallergic activity of curcumin was determined in vivo. The
authors concluded that curcumin not only blocked the antigen-
mediated activation of mast cells but also inhibited the secretion
of cytokines like TNF-α and IL-4 by the mast cells, the underlying
pathophysiology of atopic allergic reactions (Lee et al., 2008).
In addition, another study indicated that curcumin inhibited
the release of histamine from the mast cells, exhibiting anti-
allergic effects in a murine model of allergy (Kurup and Barrios,
2008). During myocardial ischemia/reperfusion injury, it was
shown that curcumin significantly lessen the myeloperoxidase
activity, an index of neutrophils infiltration, hence alleviating
cardiomyocytic apoptosis and global ischemia (Yeh et al., 2005).
A new series of curcumin analogs with α,β-unsaturated
moiety i.e., pyrano pyridines, pyrazole pyridines, and pyrido
pyrimidines has also revealed the antioxidant potential
against free radical scavenging activity in isolated peripheral
multinuclear neutrophils cells (PMNs) from the blood of
healthy donors. Among the compounds tested, compound
4 exhibited the highest antioxidant activity (Al-Omar et al.,
2005). Bukhari et al. (2015) assessed the inhibitory abilities
of 17 diarylpentanoid analogs of curcumin against ROS
production. The chemiluminescence assay was performed by
using isolated PMNs and it was reported that compounds 5 and
6 showed strong inhibition on intracellular and extracellular
ROS production by neutrophils with IC50 values ranging
from 4.2 to 6.2 uM. In another study, a synthetic curcumin
analog (7) exhibited a strong antioxidant activity by inhibiting
neutrophils-mediated free radical scavenging activity against
diphenylpicrylhydrazyl free radical test (DPPH; Youssef et al.,
2004). Investigation on the immunomodulatory effects of 43
curcumin diarylpentanoid analogs revealed that compounds 8,
10, 13, and 14 were found to possess marked inhibitory effect on
the oxidative burst of PMNs as well as compounds 9, 10, 11, 12,
and 15 which exhibited potent inhibition of migration of PMNs
(Jantan et al., 2012).
Immunosuppressive Effects of Chalcone
and Its Derivatives on Granulocytes
Chalcone derivatives have also been found to play an
important role on neutrophil’s activities and functions.
Kimura et al. (1988) reported that two chalcones i.e., 2-
methoxy-4,4′-dihyroxy-5-α,α-dimethyl-allyl chalcone (16)
and 2-methoxy-3,4,4′-trihydroxychalcone (17) isolated from
Glycyrrhiza glabra inhibited the biosynthesis of leukotrienes,
LTB4 and LTC4 in human neutrophils. The synthesis of
leukotrienes was stimulated by calcium-ionophore and was
considered to be involved in the pathology of various diseases.
Broussochalcone A (18), found in Broussonetia papyrifera, has
showed a dose-dependent inhibition of fMLP and PMA elicited
respiratory burst in activated rat neutrophils. Inhibition of PKC
activity and suppression of NADPH oxidase activity were among
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TABLE 1 | Effects of α,β unsaturated carbonyl-based compounds on immune cells.
Type of
cells
α,β-unsaturated carbonyl based
compounds
Model used Key effects References
CURCUMIN AND CURCUMIN ANALOGS
Neutrophils Curcumin Monkey ↓Production of ROS Srivastava, 1989
Curcumin Murine ↓Raised level of PKC enzymes Jancˇinová et al., 2009
Curcumin Chondrocyte ↓Inflammatory process Jackson et al., 2006
Curcumin Human ↓Chemotaxis
↓IL 8 induced signal transduction pathway
Takahashi et al., 2007
Curcumin Human ↓Cytokine induced neutrophil chemo attractant Lian et al., 2006
Diarylpentanoid analogs Human ↓ROS production Bukhari et al., 2015
Pyranopyridine,pyrazole pyridines and
pyridopyrimidines
Human ↓ROS production Al-Omar et al., 2005
Synthetic curcumin analog Human ↓ROS production Youssef et al., 2004
Eosinophils Curcumin Murine ↓Migration and IL-4 and IL-5 synthesis Moon et al., 2008
Mast cells Curcumin Murine ↓TNF-αand IL-4
↓Histamine release
Lee et al., 2008;
Kurup and Barrios, 2008
Monocytes
/macrophages
Curcumin Human ↓Adhesion to human endothelial cells Kumar et al., 1998
Curcumin Human ↓TNF-α, IL-8, MiP-1α, MCP-1, IL-1β Abe et al., 1999
Curcumin U937 cells ↓MCP-I Lim and Kwon, 2010
Curcumin Murine ↓NO, TNF-α, IL-8 Bisht et al., 2009
Curcumin Murine ↓TLR4 mRNA expression Matsuguchi et al., 2000
Curcumin U937 cells ↓Oxidative stress, IL-8, TNFα, IL-6 Jain et al., 2009
Curcumin ↓Amyloid β-deposition Hamaguchi et al., 2010
Curcumin THP-1 ↓TNF-α,IL-1β,MCP-1,IL-8,MIP-1β, CCR5 Giri et al., 2004
Curcumin THP-1 ↓Th1 cytokine response, ↓NO production Bhaumik et al., 2000
Curcumin Human ↓Release of TNF and IL-1 Chan, 1995
Dibenzoyl methane, Tetrahydrocurcumin and
Trimethoxydibenzoylmethane
Murine ↓COX-2 expression, ↓5-LOX activity ↓PLA2
phosphorylation
Hong et al., 2004
Bis dimethoxy curcumin Murine ↓NO production Kim et al., 2010
Diacetyl curcumin manganese complex ↓NO production Sumanont et al., 2004
Hexahydrocurcumin Murine ↓PGE2 synthesis, ↓iNOS Lee et al., 2005
Unsymmetrical monocarbonyl curcumin
analogs
Human and
Murine
↓PGE2 synthesis Aluwi et al., 2016
Demethoxycurcumin Murine ↓NO production, ↓iNOS Pae et al., 2008
Diarylpentanoid analogs of curcumin Murine ↓NO production Lee et al., 2009
Diarylpentene dione curcumin series Murine ↓NO production Leong et al., 2014
2 benzoyl-6-benzylidene cyclohexanone
curcumin series
Murine ↓NO production Leong et al., 2015
1,5 diphenylpenta-2,4-dien-1-one Murine ↓TNF-α and IL-6 Liang et al., 2009a
Monocarbonyl curcumin analogs Murine ↓TNF, IL-1, IL-6,MCP-1,COX-2,PGE2,iNOS Liang et al., 2009b
Asymmetric monocarbonyl analogs Murine ↓TNF- α, IL-6 Zhao et al., 2015
Curcumin analogs Murine ↓TNF- α, IL-6 Zhang et al., 2015
Symmetric and asymmetric monocarbonyl
curcumin analogs
Murine ↓TNF- α, IL-6 Zhang et al., 2014
Dendritic
cells
Curcumin Human ↓Proliferation of helper T-cells Shirley et al., 2008
Curcumin Murine ↓Activities of regulating T-cells,
↓Oversuppression of CD 86, CD80, MHC II
Kim et al., 2005
Curcumin Murine ↓Of indoleamine 2,3 dioxygenase Platt et al., 2010
Curcumin Murine ↓IDO production and T-cell proliferation Jeong et al., 2009
(Continued)
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TABLE 1 | Continued
Type of
cells
α,β-unsaturated carbonyl based
compounds
Model used Key effects References
Curcumin Murine ↓IL-12/23p40 Larmonier et al., 2008
T cells Curcumin Murine ↓Release of IL-2 and IFN-γ Gao et al., 2004
Curcumin Jurkat ↓Proliferation of rat thymocytes Sikora et al., 1997
Curcumin Human ↓Quiescent T-cells Magalska et al., 2006
Curcumin Murine ↓OKT3 monoclonal antibody Sikora et al., 2006
Curcumin Human ↓Proliferation Deters et al., 2008
Curcumin Murine ↓Proliferation, ↓IL-2 and IFN-g Gao et al., 2004
Curcumin Murine ↓IL-17 level,IL-17 mRNA expression Xie et al., 2009
Curcumin Murine ↓TLR4 and TLR9 receptor expression Chearwae and Bright, 2008
Curcumin Murine ↓IL-12 production Natarajan and Bright, 2002
Curcumin Human ↓Lymphocyte proliferation Moon et al., 2010
B cells Curcumin ↓Proliferation and induce apoptosis Han et al., 1999
Curcumin Murine ↓Proliferation Decoté-Ricardo et al., 2009
Curcumin Murine ↓Proliferation and release of IgG1 and IgG2 Sharma et al., 2007
Curcumin Murine ↓Release of IgE antibodies Kuramoto et al., 1996
Curcumin Human ↓B-cell immortalization Ranjan et al., 1998
Curcumin Human ↑Apoptosis Ranjan et al., 1999
Natural killer
cells
Curcumin Murine ↓LAK cell production Gao et al., 2004
Curcumin Human ↓Release of IFN-γ and granzyme B Bill et al., 2009
Curcumin TS/A cell line ↓Function and activity Zhang et al., 2007
Curcumin Murine ↓Proliferation Yadav et al., 2005
Curcumin ↓Proliferation Kim et al., 2005
ZERUMBONE AND ITS DERIVATIVES
Neutrophils Zerumbone Murine Blocking infiltration of PMNs Chen et al., 2011
Eosinophils Zerumbone Murine Prevent eosinophilic pulmonary infiltration Shieh et al., 2015
Monocytes/
macrophages
Zerumbone Murine ↓COX-2 expression Murakami et al., 2005
Zerumboneoxide Murine ↓NO production Jang et al., 2005
Zerumbone Murine ↓NO production Syahida et al., 2006
Zerumbone THP1 cells ↓AP-1 and NF-κB Eguchi et al., 2007
Zerumbone Murine ↓PGE2 and NO production Chien et al., 2008
Zerumbone Mouse
monocytes
and human
breast tumor
cells
↓RANKL-induced NF-κB activation, ↓IκBα
kinase
Sung et al., 2009
Zerumbone Murine ↓COX-2 and iNOS Ohnishi et al., 2009
zerumbone and zerumbone 2,3-epoxide Murine ↓NF-κB activation
↓NO production
Giang et al., 2009
Zerumbone U937 cells U937 macrophages protection from TCDD and
DDT mediated the toxic actions
Sciullo et al., 2010
Zerumbone Murine ↓mRNA, iNOS and IL-1β. Igarashi et al., 2016
Dendritic
cells
Zerumbone Murine ↓Antigen presenting cells (type A) Ganabadi and Kadir, 2009
Zerumbone Murine ↓Production of eotaxin, KC, IL-4, IL-5, IL-10,
and IL-13
Shieh et al., 2015
(Continued)
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TABLE 1 | Continued
Type of
cells
α,β-unsaturated carbonyl based
compounds
Model used Key effects References
T cells Zerumbone ↑Apoptosis Abdelwahab et al., 2011
Zerumbone Jurkat ↓T- cells proliferation ↑apoptosis Rahman et al., 2014
CHALCONE AND CHALCONE DERIVATIVES
Neutrophils 2-methoxy-4,4′ dihydroxy-5- α, α-dimethyl ally
chalcone
Human Biosynthesis of LTB4 and LTC 4 Kimura et al., 1988
2-methoxy-3,4,4′ trihydroxychalcone Human Biosynthesis of LTB4 and LTC 4 Kimura et al., 1988
Viscolin Human ↓Free radical production and elastase secretion Hwang et al., 2006
Brousso chalcone A Human ↓Respiratory burst Wang et al., 1997
2′,5′ dihydroxy-2-naphthyl chalcone Neutrophil degranulation Hsieh et al., 1998
(E) -1-[2-hydroxy-4-methoxy-3-(morpholine-
methyl)phenyl]-3-(pyridine-2-yl)prop-zen-1-one
Human ↓Production of superoxide ion and elastase
release
Reddy et al., 2011
(E) -1-[4-ethoxy-2-hydroxy-5-(-(morpholine-
methyl)phenyl]-3-(pyridine-2-yl)prop-zen-1-one
Human ↓Production of superoxide ion and elastase
release
Reddy et al., 2011
Phenyl sulfonyl uranyl Murine ↓Chemotaxis, ↓MPO, ↓ROS, ↓Elastase, ↓LTB4
production, ↓elastase, superoxide anion and
LTB4
Araico et al., 2006
1-(2,3,4 trimethoxyphenyl)-3-(3-2-
chloroquinolinyl)-2-propen-1-one
Human and
Murine
↓Elastase, superoxide anion and LTB4 De Leon et al., 2003
Bratelactone Human ↓Elastase release and superoxide synthesis Wu et al., 2013
2′,5′ dihydroxy-2-furfuryl chalcone Murine ↓Respiratory burst Wang et al., 2003
Basophils Chalcone Human ↓Histamine release Middleton and Drzewiecki,
1984
Liccochalcone RBL-2H3
cells
↓Activation of ERK pathway Tanifuji et al., 2010
4′-o-B-D-glucopyronosyl-4-hydroxy-3′-
methoxy chalcone
Human ↓Release of intra granular mediator Middleton and Drzewiecki,
1984
4′-o-B-D-glucopyronosyl-4-hydroxy-3′-
dimethoxy chalcone
Human ↓Release of intra granular mediator Middleton and Drzewiecki,
1984
Monocytes
/macrophages
2′,4′,6′tris(methoxy methoxy)chalcone Murine ↓NO production, ↓iNOS Lee et al., 2006
2,4,6 trimethoxy acetophenone Murine ↓NO production Chiaradia et al., 2008
Trans -1,3-diphenyl-2,3-epoxypropane-1-one Murine ↓NO and PGE2 production Kim et al., 2013
3-phenyl-1-(2,4,6-tris(dimethoxy)phenyl)prop-
2-yn-1-one
Murine ↓AP-1 and ↓NO, ↓TNF- α Park et al., 2009
4-dimethylamino-3′,4′ dimethoxy chalcone Mice ↓iNOS expression Herencia et al., 2001
2′,4-dihydroxy-6′-isopentlyoxy chalcone Murine ↓TLP4 mediated NFK-β activation Roh et al., 2011
Sofalcone Murine ↓TNF-α, MCP-1, NO Tanaka et al., 2009
Naringenin Murine ↓TNF-α, MCP-1, NO Hirai et al., 2007
Okanin Murine ↓iNOS and NO Kil et al., 2011
Phenyl Sulfonyl Uranyl chalcone Murine ↓PGE2 Araico et al., 2006
Dendritic
Cells
Licochalcone A Human ↓Release of IL-6 and TNF-α Kolbe et al., 2006
Xanthohumol Murine ↑Apoptosis Xuan et al., 2010
T cells Chalcone Murine ↓Production and function of CD8+ cells Schwartz and Middleton,
1984
Xanthohumol Murine ↓Proliferation of CD8+ T-cells and ↓Release of
IL-2,IFN-γ and TNF-α
Gao et al., 2009
Dendritic
cells
Zerumbone Murine ↓Antigen presenting cells (type A) Ganabadi and Kadir, 2009
Licochalcone A Human ↓Proliferation and release of IFN-γ Barfod et al., 2002
Naringenin Murine ↓Release of Th-2 cytokines Iwamura et al., 2010
Naringenin Murine ↑T-cell apoptosis, ↓mRNA expression of IL-2,
IFN-γ and TNF-α
Fang et al., 2010
* ↑, Enhanced/Upregulation; ↓, Decreased/Inhibited/Downregulation.
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FIGURE 3 | Chemical structures of α,β-unsaturated carbonyl-based compounds with strong immunosuppressive effects on granulocytes.
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FIGURE 4 | Chemical structures of α,β-unsaturated carbonyl-based
compounds with strong immunosuppressive effects on monocytes
and macrophages.
the different contributing factors exhibiting the aforementioned
effects (Wang et al., 1997).
Hsieh et al. (1998) reported the anti-inflammatory effects
of a newly synthesized 2′,5′-dihydroxy-2-naphthylchalcone
(19) which blocked fMPL-activated rat neutrophils which
further blocked the release of β-glucuronidase and lysozyme.
Human neutrophils mediated anti-inflammatory responses
by viscolin (20), a chalcone isolated from Viscum coloratum
has been reported. It was observed that viscolin suppressed
the free radicals production and elastase release by the fMLP
stimulated human neutrophils and these effects were found
to be associated with an enhanced levels of cellular cyclic
adenosine monophosphate (cAMP) through the inhibition
of cAMP-specific phosphodiesterase (PDE) degradative
enzymes (Hwang et al., 2006). In another study, Mannich
bases of heterocyclic chalcones i.e., (E)-1-[2-hydroxy-4-
methoxy-3-(morpholinomethyl)phenyl]-3-(pyridin-2-yl)prop-2
-en-1-one (21) and (E)-1-[4-Ethoxy-2-hydroxy-5-
(morpholinomethyl)phenyl]-3-(pyridin-2-yl)prop-2-en-1-one
(22) exhibited similar inhibitory effects (production of
superoxide anion and elastases) in human neutrophils (Reddy
et al., 2011).
Another chalcone derivative, phenylsulfonyl uranyl has been
reported to reduce the chemotaxis process during inflammatory
conditions. Also it seemed to be suppressing myeloperoxidase
generation along with the production of elastases and oxygen
free radicals in neutrophils stimulated by different inducers
including PMA, fMLP, and cytochalasin B. These effects
are correlated with the inhibition of LTB4, an important
leukotriene synthesized by the enzyme 5 lipoxygenase during the
lipoxygenase pathway (Araico et al., 2006). Furthermore,
De Leon et al. (2003) also studied the aforementioned
parameters with the synthetic chalcone derivative, 1-(2,3,4-
trimethoxyphenyl)-3-(3-(2-chloroquinolinyl)-2-propen-1-one
(23) and documented its inhibitory function on neutrophils.
The anti-inflammatory effects through the inhibition of CD11b
expression, elastase release and free radicals generation in fMLP
activated neutrophils have been exhibited by a novel chalcone,
bratelactone, (24) isolated from Fissistigma bracteolatum. The
observed underlying mechanism involved the blockage of
calcium signaling, particularly store operated calcium entry
block (SOCE) which is considered of paramount importance in
activation of human neutrophils (Wu et al., 2013). Phospholipid
D, an important component involved in the synthesis of
phosphatidic acid, required for the activation of NADPH oxidase
which is further important for neutrophil activation. Therefore,
the inhibition of phospholipase D activation, by blocking
PKC, Rho A, and ADP-ribosylation factor (ARF) membrane
association is one of the critical mechanism in suppressing
neutrophil’s function. Another chalcone derivative, namely, 2′,
5′-dihydroxy-2-furfurylchalcone (DHFC) (25) has manifested
dose-dependent inhibition of oxidative burst in fMLP activated
neutrophils employing same mechanism as stated earlier (Wang
et al., 2003).
Middleton and Drzewiecki (1984) revealed the inhibitory
effects of chalcones on the release of histamine, an important
cell derived inflammatory mediator, by human basophil. The
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FIGURE 5 | Chemical structures of α,β-unsaturated carbonyl-based compounds with strong immunosuppressive effects on dendritic cells.
authors studied the effect of different inducers antigen, anti-
IgE, concanavalin (CON-A), ionophore, fMLP, and tetrade-
canoylphorbol acetate to stimulate basophil cells. Likewise,
Itoh et al. (2010) reported the anti-allergic role of two
chalcone derivatives i.e., 4′-O-β-D-glucopyranosyl-4-hydroxy-
3′-methoxychalcone (26) and 4′-O-β-D-glucopyranosyl-3′,4′-
dimethoxychalcone (27) isolated from Brassica rapa L. using rat
RBL-2H3 basophilic cells. The results revealed that chalcones
inhibited the release of intra granular mediators in response
to an antigen stimulus. Another study demonstrated the same
inhibitory effects in rat RBL-2H3 basophilic cells by a chalcone
derivative namely; licochalcone D (28) isolated from the root
Xinjiang liquorice. These antiallergic effects accounted for their
capability to inhibit the activation of the extracellular signal
regulated kinase pathway (ERK) and extracellular Ca2+ influx
(Tanifuji et al., 2010).
Immunosuppressive Effects of Zerumbone
on Granulocytes
Chen et al. (2011) demonstrated the effect of zerumbone
on ultraviolet B (UVB)-induced corneal damages in female
imprinting control region (ICR) mice where infiltration of
PMNs was significantly blocked by the treatment of dietary
zerumbone. The UVB-induced corneas were found to contain
infiltrative PMN leukocytes in stroma and aqueous humor.
Few PMN leukocytes were shown to attach with endothelial
layer possessing a significant risk of attack to endothelial cells
of cornea. Zerumbone was found to ameliorate UVB-treated
corneal damages. It has been evidenced that infiltration of
PMN leukocytes was suppressed with dietary zerumbone in a
concentration-dependent manner. Recently, Shieh et al. (2015)
reported that zerumbone has the ability to prevent eosinophilic
pulmonary infiltration. Treatment with zerumbone inhibited the
airway inflammation followed by reducing eotaxin production in
murinemodel of asthma. Eotaxin is a most significant chemokine
for recruiting eosinophils. Investigating this chemokine level
in bronchoalveolar lavage fluid (BALF) revealed that treatment
with zerumbone remarkably inhibited the eotaxin secretion.
This inhibition of eotaxin level thought to be due to the
direct or indirect influence exhibited on recruiting eosinophils.
Furthermore, the less infiltration and activation of eosinophils in
the lung of zerumbone-induced mice thought to have revealed
in inhibited IL-5 expression in BALF as eosinophils are also
considered for the source of IL-5.
Immunosuppressive Effects of Curcumin
on Monocytes and Macrophages
The inflammatory responses mediated by monocytes and
macrophages play a pivotal role in chronic inflammatory
conditions. Kumar et al. (1998) reported that curcumin exhibited
anti-inflammatory effects by blocking the adhesion of monocytes
on human endothelial cells. These effects have been attributed to
the inhibition of NF-κB which is responsible for the expression of
proteins like ICAM-1, VCAM-1, and endothelial cell leukocyte
adhesion molecule-1 (ELAM-1) on monocytes, induced by
TNF. Also it has shown concentration-dependent inhibition
of certain inflammatory cytokines secretion i.e., TNF-α, IL-8,
macrophage inflammatory protein 1 alpha (MIP-1α), monocyte
chemoattractant protein (MCP-1) and IL-1β after monocytes and
macrophages had been stimulated by PMA or lipopolysaccharide
(LPS; Abe et al., 1999). Lim andKwon (2010) also revealed similar
findings in their study that curcumin suppressed the expression
of MCP-1 in PMA-induced U937.
Monocytic cell lineage. MCP-1 is a key factor in macrophages
migration toward the site of infection and this inhibition has been
subjected to the blocking of ERK /and NF-κB transcriptional
activity. Another study was conducted to determine the anti-
inflammatory role of curcumin by assessing different functions
of macrophages viz NO production, phagocytosis and cytokines
release. It was recognized that this multi targeting agent inhibited
the synthesis of NO along with the blocking of TNF-α and IL-8
secretion by raw macrophages triggered by LPS. On the other
hand, it enhanced the phagocytic activity and CD14 surface
expression which was suggested as an indirect role of curcumin
with unknown mechanism (Bisht et al., 2009).
Matsuguchi et al. (2000) observed the effects of curcumin
on expression of toll like receptors in mouse macrophages in
response to intraperitoneal injection of LPS. The results showed
that pretreatment with curcumin significantly suppressed TLR4
mRNA expression which was subjected to NF-κB inhibition,
suggesting that NF-κB is essential for this process. In diabetic
condition, a massive increase in the inflammatory cytokines has
been reported. In a model of streptozotocin-induced diabetic
rats, the anti-inflammatory effect of curcumin was evaluated
on the secretion of various inflammatory cytokines and also
these effects were studied by using human promonocytic U937
cell line. Treatment with curcumin not only reduced enhanced
levels of IL-8, TNF-α, IL-6, MCP-1 secreted as a result of
increased glucose levels but also reduced cellular oxidative stress
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(Jain et al., 2009). Alzheimer’s disease is a disorder presented
mainly with massive amyloid-β (Aβ) peptide and monocytes
and macrophages accumulation in the affected tissue. Increased
levels of cytokines, TNF-α, and IL-1β and chemokines MCP-1,
IL-8, and MIP-1β have also been observed. The ability of
curcumin to modulate β-secretase and AChE activities led to
decreased amyloid-β deposition and macrophages accumulation
(Hamaguchi et al., 2010). Correspondingly, Giri et al., 2004) also
explained the anti-inflammatory role of curcumin in Alzheimer’s
disease. It was reported that curcumin inhibited amyloid-β
peptide aggregation and Aβ-induced expression of TNF-α, IL-1β,
MCP-1, IL-8, MIP-1β, and CCR5 in THP-1 monocytic cells. In a
model of subcutaneously transplanted AK-5 tumors, curcumin
led to the suppression of type 1 T helper (Th1) cells cytokine
response and NO production by macrophages, suggesting that
the host macrophages played an important modulatory role in
the remission of AK-5 tumor (Bhaumik et al., 2000). Curcumin
has also been found to hamper the release of TNF and IL-l as a
result of inhibition of NF-κB by human monocytic macrophages
triggered by LPS. This pleiotropic cytokines play a crucial
role in different acute and chronic inflammatory diseases e.g.,
atherosclerosis, AIDS and autoimmune disorders (Chan, 1995).
Likewise, Gao et al. (2004) also investigated the suppression
of aforementioned cytokines in peritoneal macrophages by
diferuloylmethane.
Immunosuppressive Effects of Curcumin
Analogs and Derivatives on Monocytes and
Macrophages
The reduced level of heme oxygenase-1 expression in RAW264.7
cells treated with bisdemethoxycurcumin (29) was found as
one of the mechanisms of LPS-mediated NO production
inhibition. Also this anti-inflammatory mechanism involved
Ca2+/calmodulin- CaMKII-ERK1/2-Nrf2 cascade in RAW264.7
macrophages (Kim et al., 2010). Anti-inflammatory activity
mediated by manganese complexes of curcumin (CpCpx) and
diacetylcurcumin manganese complex (AcylCpCpx) exhibited
enhanced NO radical scavenging activity as compared to their
parent compounds, curcumin and acetylcurcumin, respectively
(Sumanont et al., 2004). Skin wound healing involves androgen
receptor signaling and these receptors have been found in
different cell types including keratinocytes, dermal fibroblasts,
and infiltrating macrophages. Lai et al. (2009) evaluated the
curcumin derivative ASC-J9, against general and myeloid-
specific AR knock out (ARKO) mice. The study concluded
that the topical application of ASC-J9 cream in mice caused
accelerated wound healing by inhibiting the androgen receptor
activity and suppressed expression of local TNF-α expression.
Anti-inflammatory activities mediated by naturally occurring
curcumin and β-diketone derivatives namely dibenzoylmethane
(30), triethoxydibenzoylmethane (31), tetrahydrocurcumin (32)
using RAW 264.7 macrophages cell line have been investigated.
The observed parameters included the release of AA and its
metabolites (Hong et al., 2004). It was concluded from the
results that curcumin and its analogs significantly affected
the AA metabolism by blocking cytosolic phospholipase
A2 (cPLA2) phosphorylation, suppressing cyclooxygenase 2
(COX-2) expression and decreasing the catalytic activities of 5
lipoxygenase (LOX) in LPS-stimulated raw macrophages.
Lee et al. (2005) evaluated newly synthesized α,β-
unsaturated curcumin analogs i.e., diarylheptanoid analogs
and diarylheptylamine analogs as COX-2 inhibitors. These
compounds strongly inhibited COX-2 catalyzed biosynthesis in
LPS-stimulated macrophages as a model system. Among all the
compounds, hexahydrocurcumin (33) was the most potent one
with an IC50 value of 0.7 µM. Also the authors reported that the
abovementioned curcumin analogs could inhibit iNOS responses
of LPS-stimulated macrophages exhibiting anti-inflammatory
activities. A series of unsymmetrical monocarbonyl curcumin
analogs were synthesized and their anti-inflammatory effects
were determined. Human and murine macrophages stimulated
by LPS to determine the effects on prostaglandin E2 (PGE2)
production were used. The results suggested that compound
34 exhibited strong inhibition on the production of PGE2 in
both cell lines (Aluwi et al., 2016). Another study investigated
a more stable synthetic curcumin analog, dimethoxycurcumin
(35), for NO production assay and compared with curcumin
and bisdemethoxycurcumin (29). LPS activated macrophages
were used to evaluate the inhibition of NO production and iNOS
expression. The results showed that compound 35, curcumin and
compound 29 inhibited NO production, iNOS expression with
compound 35 being the most effective, followed by curcumin
and compound 29, confirming that α,β-unsaturated carbonyl
group is an important reactive structure of curcumin analogs.
Additionally, this compound also revealed the inhibition of
NF-κB in LPS-activated raw macrophages. Further mechanistic
elucidation demonstrated that diminished NF-κB activation was
achieved by blocking IκBα phosphorylation and IKK-α activity
(Pae et al., 2008).
A newly synthesized series of curcumin related
diarylpentanoid analogs have been shown to possess anti-
inflammatory activity. Among the 46 compounds tested,
three curcumin-like diarylpentanoid analogs which were 36,
37, and 38 showed remarkably high inhibitory effect upon
NO production in RAW 264.7 cell line, as compared to
positive control and curcumin. Inhibition of target protein
was suggested as the mechanism responsible for the anti-
inflammatory property of these compounds (Lee et al., 2009).
Likewise, a series of 97 diarylpentanoid derivatives with
diarylpentenedione series (halogenated, methoxylated, and
polyphenolic) were synthesized and screened through NO
suppression assay for their anti-inflammatory activity using
interferon gamma (IFN-γ)/(LPS)-stimulated macrophages cells.
However, compound 39 demonstrated the most significant
NO suppression activity. The authors concluded their
study by reporting that the diarylpentanoid structure with
preserved ethylene and β-diketone moieties was a primary
direction and should be investigated further toward finding new
anti-inflammatory agents (Leong et al., 2014).
In another study, compound 40 belonging to 2-benzoyl-
6-benzylidenecyclohexanone curcumin analogs series was
evaluated for NO inhibition in LPS/IFN-induced RAW 264.7
macrophages model and was found to exhibit the highest
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activity with an IC50 value of 4.2 ± 0.2 µM (Leong et al.,
2015). Analogously, in a model of IFN-γ/LPS-activated RAW
264.7 cells, similar results have been seen when a series of 1,
5-diphenylpenta-2, 4-dien-1-one analogs was evaluated for
anti-inflammatory activity by measuring their NO inhibition
activity (Faudzi et al., 2015). The most promising NO-inhibitory
activity was displayed by compound 41, a 5-methylthiophenyl-
bearing analog. As a sequence from previous study, the authors
investigated the bioactivity of a newly synthesized compound 42
against LPS-induced TNF-α and IL-6 secretion by using mouse
J774.1 macrophages (Liang et al., 2009a). Liang et al. (2009b)
evaluated another 44 mono-carbonyl analogs for the inhibitory
activities against LPS-induced TNF-α and IL-6 release in the
macrophages. Among these compounds, three were selected to
further evaluate the inhibitory effects on LPS-induced TNF-α,
IL-1, IL-6, MCP-1, COX-2, PGES, iNOS, and p65 NF-κB mRNA
production and it was observed that compound 43 exhibited
significant inhibitory effects.
Newly synthesized 23 mono-carbonyl analogs of curcumin
demonstrated anti-inflammatory activity in one study and
among these, compounds 44 and 45 were recorded as the
most potent analogs exhibiting anti-inflammatory activity in a
dose-dependent manner. Their anti-inflammatory abilities were
examined against TNF-α and IL-6 release in LPS-stimulated
RAW 264.7 macrophages (Zhao et al., 2010). In another study,
the author found that compound 46, a 2-nitro-substituted analog
significantly (with the highest inhibition rate) suppressed the
production of TNF-α and IL-6 in LPS-stimulated macrophages.
Further investigation into the possible mechanism revealed that
the anti-inflammatory activity of the analog might be associated
with its inhibition against LPS-induced NF-κB and ERK pathway
activation (Zhao et al., 2015). A very similar result was reported
by evaluating the newly designed curcumin analogs for their anti-
inflammatory effects in mouse peritoneal macrophages using
ELISA kits. Active compound 47 exhibited highest inhibition
on LPS-induced production of TNF-α and IL-6 and showed
high chemical stability confirmed by UV absorption spectra
(Zhang et al., 2015). In another study, the author classified
the newly synthesized 34 monocarbonyl curcumin analogs
into two series, symmetric monocarbonyl analogs of curcumin
(SMAC) and asymmetric monocarbonyl analogs of curcumin
(ASMAC). Among the analogs, the symmetrical heterocyclic type
(compound 48 and 49) displayed the strongest inhibition against
LPS-induced TNF-α and IL-6 release in mouse macrophages
(Zhang et al., 2014).
Immunosuppressive Effects of Zerumbone
and Its Derivatives on Monocytes and
Macrophages
Zerumbone exhibited immunosuppressive effects on LPS-
induced COX-2 expression in RAW264.7 murine macrophages
followed by several mode of action (Murakami et al., 2005).
Interestingly, a study reported that zerumbone derivatives, 5-
hydroxyzerumbone and zerumboneoxide (50) suppressed LPS-
induced NO production in RAW 264.7 cells with IC50 values of
14.1 and 23.5 µM, respectively (Jang et al., 2005) (Figure 4). In
IFN-γ/LPS induced RAW 264.7 macrophages model, zerumbone
also displayed more than 90% inhibition of NO production at
the concentration of 50 µM (Syahida et al., 2006). Another
study was carried out with differentiated Caco-2 cell lines
to investigate the inhibitory effects of 16 selected food items
on tissue plasminogen activator (TPA)-induced LOX-1 mRNA
expression in THP-1 monocyte-like human cells and it was
reported that zerumbone suppressed the transcriptional activities
of activator protein (AP-1) and NF-κB (Eguchi et al., 2007).
Zerumbone has also been documented as an inhibitor of PGE2
and NO production (Chien et al., 2008). Sung et al. (2009)
found zerumbone to inhibit receptor activator for NF-kB ligand
(RANKL) induced NF-κB activation in the mouse monocytes
through the suppression of activation of IκBα kinase, IκBα
degradation and IκBα phosphorylation as well as found to
suppress osteoclast formation induced by human breast tumor
cell lines.
The inhibition of pro-inflammatory genes (COX-2 and iNOS)
expression and enhanced detoxification genes gluthathione-S-
transferases (GSTP1) and nicotinamide quinone oxidoreductase
(NQO1) in RAW264.7 murine macrophages have been revealed
by zerumbone (Ohnishi et al., 2009). In another comparative
study, zerumbone and zerumbone 2,3-epoxide inhibited NF-
κB activation and NO production in RAW 264.7 murine
macrophages with respective IC50 values of 1.97 µM ± 0.18
and 30.11 µM ± 4.10 in activation of NF-κB assay and 3.58
µM ± 0.46 and 34.7 µM ± 3.72 in the NO production assay
(Giang et al., 2009). Likewise, 5-hydroxyzerumbone found to
suppress NO production in a dose-dependent manner with IC50
value of 19 µM (Min et al., 2009). In addition to RAW 264.7
macrophages, zerumbone has also been identified as a potential
agent in protecting U937 macrophages from tetrachlorodibenzo-
p-dioxin (TCDD) and dichlorodiphenyltrichloroethane (DDT)-
mediated toxic actions (Sciullo et al., 2010). An intriguing study
narrated the zerumbone-induced heat shock factor 1 (HSF-1)
activation in stimulated macrophages for its anti-inflammatory
functions. The outcomes revealed that zerumbone enhanced
cellular protein aggregates and found to promote nuclear
translocation of HSF-1 for heat shock protein (HSP) expression.
Moreover, down-regulation of HSF1 attenuated the inhibitory
effects of zerumbone on expressions of mRNA and proteins of
pro-inflammatory genes, including iNOS and IL-1β (Igarashi
et al., 2016).
Immunosuppressive Effects of Chalcone
and Its Derivatives on Monocytes and
Macrophages
Inhibition of NO synthesis by altering the expression of induced
enzymes is one of the essential mechanisms to attain anti-
inflammatory activity. Synthetic chalcones with α,β-unsaturated
moiety, namely 2′,4′,6′-tris(methoxymethoxy) chalcone has also
been reported to retard NO production by inhibiting iNOS
expression along with the inhibition of NF-κB translocation into
the nucleus in RAW 264.7 macrophages fostered by LPS (Lee
et al., 2006). In a similar manner, 14 synthetic chalcones derived
from 2,4,6-trimethoxyacetophenone revealed inhibitory action,
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in vitro, in relation to NO production in murine macrophages
of the line RAW 264.7 induced by bacterial LPS (Chiaradia
et al., 2008). Analogously, trans-1,3-diphenyl-2,3-epoxypropane-
1-one (51), another chalcone derivative has disclosed the reduced
production of NO and PGE2 in RAW 264.7 macrophages
stimulated by LPS as a consequence of suppressed iNOS
and COX-2 expression. Meanwhile, the reduced production of
proinflammatory cytokines (TNF-α, IL-1β, and IL-6) has also
been documented by compound 51 which was associated with the
blocking of NF-κB activities as well as mitogen activated protein
kinase (MAPK) phosphorylation. These twomechanisms seemed
to be prominent in the pathophysiology of several inflammatory
conditions (Kim et al., 2013).
The anti-inflammatory role of chalchone derivative i.e.,
3-phenyl-1-(2,4,6-tris(methoxymethoxy)phenyl)prop-2-yn-1-
one (52) was described by assessing the activity of AP-1 along
with NO synthesis in murine RAW 264.7 macrophages (Park
et al., 2009) The study revealed that the compound significantly
suppressed the expression of certain AP-1 protein subunits
induced by LPS and hence reduced the transcriptional activity
of AP-1. The researchers also reported a dose-dependent
abrogation of LPS-induced TNF-α secretion by a chalcone
derivative (Franck et al., 2008). The inhibition of LPS stimulated
NO and TNF-α production in RAW 264.7 macrophages
by 2′-hydroxy-4′-methoxychalcone (53), 2′,4-dihydroxy-4′-
methoxychalcone (54), and 2′,4-dihydroxy-6′-methoxychalcone
(55) was attributed to the suppression of NF-κB and AP-1
activation that are considered indispensable for iNOS and
cytokine gene expression (Figure 4; Ban et al., 2004).
Recently, a study also expressed that chalchone derivatives,
(E)-1-[3-Hydroxy-4-(morpholinomethyl)phenyl]-3-(pyridin-
4-yl)prop-2-en-1-one (56) and (E)-1-[3-Hydroxy-2,4-
bis(morpholinomethyl)phenyl]-3-(pyridin-2-yl)prop-2-en-
1-one (57) caused the prevention of NO synthesis in LPS-
and IFN-γ-stimulated RAW 264.7 macrophages (Reddy et al.,
2011). Besides, 4-dimethylamino-3′,4′-dimethoxychalcone
(58) showed iNOS expression downregulation in cultured
peritoneal macrophages extracted from mice (Herencia et al.,
2001). On the other hand, a chalcone derivative, 2′,4-dihydroxy-
6′-isopentyloxychalcone (JSH) (59) exhibited the inhibition
of toll like receptors (TLR4)-mediated NF-κB activation in
LPS-induced macrophages. These tolls like receptors (TLR-4)
are usually manifested in macrophages and are imperative for
eliciting innate immune responses (Roh et al., 2011). Tanaka et al.
(2009) and Hirai et al. (2007) depicted that naringenin chalcone
(60) and sofalcone (20-carboxymethoxy-4,40-bis(3-methyl-
2-butenyloxy)chalcone) (61) showed their anti-inflammatory
abilities by dose-dependent inhibition of LPS-induced TNF-α,
MCP-1, and NO production in RAW 264.7 macrophages. The
inhibitory effect of sofalcone on NO production was attributed
to the activation of an enzyme (HO-1 expression) which plays a
pivotal role in regulating the inflammatory condition (Tanaka
et al., 2009).
Analogously, Kil et al. (2011) also reported, a naturally
occurring chalchone, okanin (62), isolated from the genus
Bidens and 3-penten-2-on inhibited LPS-induced iNOS
expression and NO production in RAW264.7 macrophages
through upregulation of HO-1 expression. Phenylsulfonyl
uranyl chalcone derivative has been found to inhibit LPS-
induced PGE2 production in RAW 264.7 macrophages in one
study. These inhibitory effects of chalcone derivatives on the
synthesis of PGE2 were correlated to the inhibition of COX-2
function selectively (Araico et al., 2006). The two chalcone
derivatives 2′,5′-dimethoxy-4-hydroxychalcone (63) and 3,4-
dichloro-2′,5′-diethoxychalcone (64) and another three synthetic
chalcones 3,5-di-tert-butyl-2′,4,5′-trihydroxychalcone (65),
2′-hydroxy-3,4-dichlorochalcone (66), and 2′,5′-dimethoxy-4-
hydroxychalcone (67) illustrated the retardation of NO synthesis
in RAW 264.7 macrophages and microglial cells activated by LPS
(Ko et al., 2003; Won et al., 2005).
Cardamonin, a chalcone derivative isolated from Artemisia
absinthium L., and chemically known as 2′,4′-dihydroxy-
6′-methoxychalcone (68), exerted anti-inflammatory effects
in LPS -stimulated THP-1 monocytic cells/ IFN-γ activated
RAW 264.7 macrophages. The inhibitory effects were seen
on TNF-α production and iNOS protein expression which
was subjected to restricted interaction of NF-κB to the
DNA (Hatziieremia et al., 2006). 3-(2-hydroxyphenyl)-1-
(5-methyl-furan-2- y-1)propenone (HMP) (69), revealed
suppression of p38/ATF-2 and AP-1 signaling pathways,
another mechanism, responsible for LPS mediated dose
dependent inhibition of NO generation in RAW 264.7
macrophages (Liew et al., 2011). Two synthetic chalchones
i.e., 3-(2,3-dimethoxy-phenyl)-1-naphthalene-1-yl-propenone
(70) 4-(4-diethylamino-phenyl)-1,1-diphenyl-but-3-en-2-one
(71) and two β-chlorovinyl chalcones have been documented to
be able to suppress IL-6 and TNF-α release in LPS triggered RAW
264.7 macrophages and THP-1 cells (Bandgar and Gawande,
2010; Jantan et al., 2014).
Immunosuppressive Effects of Curcumin
on Dendritic Cells
Dendritic cells (DCs) are of paramount importance in producing
several immune responses and hence play fundamental role
in different chronic pathological conditions. These cells have
a pivotal role in initiating cell-mediated immunity and
modification of dendritic cell’s functions might be advantageous
in eradicating immune disorders. A number of studies have
investigated the immunomodulatory role of curcumin on
dendritic cell’s activities and functions. Curcumin owing to
its immunosuppressive effects prevented the dendritic cells
to respond to immune stimulants like LPS and proliferation
of helper T cells. These inhibitory effects were subjected to
suppression of maturation marker, cytokine and chemokine
expression which further blocked the process of migration
and endocytosis (Shirley et al., 2008). A study showed that
curcumin could modulate dendritic cells mediated distinct
immune responses in autoimmune disorders. It was reported
that curcumin not only impeded the dendritic cell’s maturation
but also inhibited the subsequent stimulatory immune functions
for regulating T cells activities. Also the over expression of
CD86, CD80 and major histocompatibility complex II (MHCII)
surface receptors were suppressed in LPS-stimulated dendritic
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cells after treatment with curcumin. It was observed that a
dose of 50 µM proved to be lethal for DCs, reflecting the
reactiveness of different immune cells to variable curcumin doses
(Kim et al., 2005).
Indoleamine 2, 3-dioxygenase (IDO) is a heme containing
immunomodulatory enzyme encoded by IDO1 gene and
produced by several immunomodulatory cells like macrophages.
On the other hand, IFN-γ, a cytokine, plays double role as an
inducer and regulator of immune and inflammatory responses.
It also regulates various responses of dendritic cells particularly,
it shape up monocyte derived dendritic cells in cancer therapy
and hence manage the polarizing activities of helper T cells 1.
In one study, it was seen that IFN-γ enhanced IDO production
in murine bone marrow derived DCs while curcumin displaying
anti-inflammatory activity suppressed IDO production in above-
mentioned cell line, further inhibiting IDO-mediated T cell
proliferation. Modulation of janus kinase 1 (JAK) and PKC
signaling pathway were recognized as mechanism for anti-
inflammatory effects of curcumin in IFN-γ stimulated murine
dendritic cells (Jeong et al., 2009).
In an in vitro model of the LPS-induced IL-12/23p40,
difurolylmethane suppressed the production of IL-12/23p40
from the dendritic cells. The data from this study also
suggested that curcumin depends on IL-10 to produce inhibitory
immune responses and therefore by acting synergistically even
at their suboptimal doses suppressed the LPS-induced IL-
12/23p40 production from DCs (Larmonier et al., 2008).
Curcumin has also been found to significantly inhibit release
of LPS-stimulated inflammatory cytokines like IL-1B, IL-6, and
TNF-α along with expression of IL-12 and dendritic cell’s
maturation which ultimately lead to poor cell -mediated immune
responses and more likely to serve as a promising therapy in
TH-1 mediated autoimmune disorders (Brouet and Ohshima,
1995).
Immunosuppressive Effects of Zerumbone
on Dendritic Cells
In a study, the role of zerumbone was investigated on the
infiltration of major histocompatibility complex (MHC) class
II cells in collagen-treated osteoarthritis of rats. The outcomes
revealed that zerumbone could inhibit APC (type A) followed
by decreasing inflammatory process in osteoarthritis (Ganabadi
and Kadir, 2009). Recently, another study documented the
immunomodulatory effects of zerumbone on APCs (DCs) in
vitro and its therapeutic role against OVA-induced T helper 2
(Th2)-mediated asthma in mouse model. The research group
reported that LPS-activated bone marrow-derived dendritic
cells along with zerumbone could enhance the proliferation
of T cells and polarization of Th1 cell. In an animal model,
oral administration of zerumbone produced lower OVA-specific
IgE (IgE) and increment of IgG2a antibody production.
Furthermore, treatment with zerumbone was found to decrease
the production of eotaxin, keratinocyte-derived chemokine (KC),
IL-4, IL-5, IL-10, and IL-13, and increase Th1 cytokine i.e.,
IFN-γ production in asthmatic mouse model (Shieh et al.,
2015).
Immunosuppressive Effects of Chalcone
and Its Derivatives on Dendritic Cells
Licochalcone A (72) blocked the secretion of IL-6 and TNF-α in
LPS stimulated immature monocyte-derived human dendritic
cells (Kolbe et al., 2006). In a detailed study, another chalcone,
xanthohumol (73), exerted apoptotic activity in mice dendritic
cells. This pharmacological effect has been recognized as a
potential target to alleviate inflammation, as xanthohumol
caused the activation of caspase 8 and caspase 3 which in turn
led to DNA frag-mentation and destruction of intracellular
proteins and hence caused apoptosis in dendritic cells
(Xuan et al., 2010).
IMMUNOSUPPRESSION OF NATURAL
α,β-UNSATURATED CARBONYL-BASED
COMPOUNDS ON THE ADAPTIVE IMMUNE
SYSTEM
Immunosuppressive Effects of Curcumin
on T Cells
Several studies have also documented the role of α,β-unsaturated
compounds on lymphocytes. Curcumin inhibited the expression
of inflammatory cytokines like IL-2 and IFN-ϒ by T lymphocytes
isolated from mouse spleen cells. Basically, the inhibition
of transcription factor i.e., NF-κB by curcumin was one of
the bottom line mechanism in suppressed cytokine release
ultimately concluding that this multi-targeting agent mediated
most of the immunosuppressive effects by obstructing NF-
κB target genes (Gao et al., 2004). Similarly, another study
reported that curcumin abrogated the proliferation of rat
thymocytes stimulated by mitogen Con A in addition to
inhibitory effects of curcumin on Con A triggered Jurkat T
cell line. These antiproliferative effects of curcumin have been
attributed to arrest AP-1 transcription factor activation (Sikora
et al., 1997). However, in disagreement to the above mentioned
study, it was also reported that curcumin could also cause
cell death not only in proliferating human lymphocytes but
also in normal non-dividing quiescent T cells via activation
of caspase-3 protein. Although, proliferating T cells were
more prone to damage as compared to quiescent T cells
(Magalska et al., 2006; Sikora et al., 2006). Moreover, in
another study the proliferation of T and B cells activated by
OKT3 monoclonal antibody (a human TCR/CD3 complex Ab)
was significantly blocked by curcumin (Deters et al., 2008).
Curcumin also showed the notable inhibition of human T
cells when these cells were stimulated by different inducers
like PMA, CD28, phytohaemagglutinin (PHA; Ranjan et al.,
1998).
Curcumin owing to its immunosuppressive effects inhibited
the proliferation of helper T cells by preventing the dendritic
cells to respond to immune stimulants like LPS. These inhibitory
effects were subjected to suppression of maturation marker,
cytokine, and chemokine expression which further blocked the
process of migration and endocytosis (Shirley et al., 2008).
Another study highlighted the effect of different doses of
curcumin on Con A-stimulated proliferation of splenic cells
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in vitro. It was observed that at 6.25 µM concentration
curcumin exhibited a significant decrease in proliferation while
a complete blockage of proliferation was observed at 12.5
µM in splenic T cells. In addition, curcumin was found to
suppress the release of IL-2 and IFN-ϒ by splenic T lymphocytes
as a result of inhibition of NF-κB target genes rather than
affecting the levels of constitutively expressed NF-κB (Gao et al.,
2004). One study documented the multiple roles of curcumin
using T cells activated by different stimuli. The IL-12-induced
STAT4 phosphorylation was found to be reduced by curcumin
while the same effect was enhanced in response to IFN-β-
induction. On the other hand, curcumin lowered IL-12 induced
IFN-γ production and IL-12 Rβ1 and β2 expression, whereas
it increased IFN-α-induced IL-10 and IFNAR1 expression
(Fahey et al., 2007).
Interleukin 17 is a pro-inflammatory cytokine produced
by T cells which further triggers T cells and other immune
cells to produce a diversity of cytokines, chemokines,
and cell adhesion molecule and plays a key role in the
progression of encephalomyelitis. In an experimental model
of encephalomyelitis, oral treatment of curcumin reduced
IL-17 levels along with IL-17 mRNA expression, production of
transforming growth factor beta (TGF-β) and also suppressed
signal transducer and activator of transcription 3 (STAT-3)
expressions and STAT3-phosphorylation. The blocked STAT3-
phosphorylation in T cells also blocked the differentiation of
Th-17 cells (Xie et al., 2009). In addition, the role of curcumin in
the pathogenesis of multiple sclerosis has also been investigated.
The results showed that curcumin inhibited the toll-like
receptors 4 (TLR4) and toll like receptors 9 (TLR9) expression on
CD4+ T and CD8+ T cells, immunized with PLPp139-151 and
MOGp35-55 antigen. Mechanistically, it was found that these
toll like receptors acted as co stimulatory receptors. Curcumin
treatment led to the decrease in the expression of PLPp139-151
and MOGp35-55 Ag-induced TLR4 and TLR9 on the CD4+
T cells and CD8+ T cells, which also ameliorated this disease.
It was found that TLR 4 and TLR9 acted as co-stimulatory
receptors which further boost the cytokine production and
proliferation in response to the specific agonists (Chearwae and
Bright, 2008). Earlier, it was narrated that the inhibitory abilities
of curcumin on IL-12 production in spleen T lymphocytes
ameliorated experimental autoimmune encephalomyelitis
(Natarajan and Bright, 2002). In a model of type II collagen
induced arthritis (CIA), curcumin abrogated lymphocytes
proliferation induced by bovine type II collagen Ag (Moon et al.,
2010). And also found to inhibit PMA induced proliferation
of T cells isolated from human spleen (Jagetia and Aggarwal,
2007). Curcumin exerted its immunosuppressive effects on T
cells by tyrosine kinase, a CD28 co-stimulatory pathway of T-cell
activation (Ranjan et al., 2004). Peripheral blood mononuclear
cells (PBMCs) are largely comprised of T cells. Maier et al.
documented that curcumin caused dose-dependent suppression
of TH-1 type immune responses in mitogen stimulated PBMCs
(Maier et al., 2010). Mechanistically, it was shown that this
suppressive effect accounts to the inhibition of neopterin
production mediated by IFN-γ along with the degradation of
tryptophan.
Immunosuppressive Effects of Zerumbone
on T Cells
Abdelwahab et al. (2011) experimented the effects of zerumbone
on T-acute lymphoblastic leukemia, CEM-ss cancer cells.
Zerumbone was found cytotoxic to CEM-ss cells with an
IC50 value of 8.4 ± 1.9 µg/mL. Additionally, zerumbone
enhanced the number of TUNEL-positive stain and cellular
level of caspase-3 on CEM-ss cells. Therefore, it’s postulated
that zerumbone has the ability to induce apoptosis on T-
acute lymphoblastic leukemia, CEM-ss cells as well as it may
help to cure leukemia. Similarly, another study was conducted
to check the effect of zerumbone loaded into nanostructured
lipid carriers (ZER-NLC) in human T-cell acute lymphoblastic
leukemia (Jurkat) cells and concluded that ZER-NLC were
able to possess antileukemic as a sustained-release drug carrier
system for treating leukemia (Rahman et al., 2013). The author
also reported the antiproliferative effect of zerumbone on T-
cells (Jurkat) through apoptotic intrinsic pathway followed by
activating caspase-3 and caspase-9 (Rahman et al., 2014).
Immunosuppressive Effects of Chalcones
and Derivatives on T Cells
Chalcones with the reactive α,β-unsaturated carbonyl group
have also been found to abrogate the production and function
of normal cytotoxic (CD8) T cells in mouse spleen (Schwartz
and Middleton, 1984). In contrast, another study documented
that chalcone isoliquiritigenin (74) exhibited no effect on
proliferation of lymphocytes induced by mitogen Con A and
also mixed lymphocyte culture from mouse spleen (Namgoong
et al., 1994). The chemical structure of compound 74 is
shown in Figure 5. The antiproliferative effects of xanthohumol
(73) as mentioned earlier were also investigated on T cells.
It was reported that xanthohumol significantly inhibited the
proliferation and development of cytotoxic T cells along with
the release of cytokines from helper T cells (Th1) i.e., IL-2,
IFN-γ, and TNF-α. These inhibitory effects were found to be
associated with the depletion of IκBα phosphorylation in the NF-
κB signaling pathway (Gao et al., 2009). In contrast, Choi et al.
(2009) demonstrated that xanthohumol enhanced the release
of cytokine IL-2 in a dose dependent fashion from PMA and
ionomycin activated mouse EL-4 T cells. These elevated effects
were attributed to the upregulation of nuclear factor of activated
T cells and AP-1 in mouse EL-4 T cells.
Barfod et al. (2002) reported that the proliferation of T cells
as well as release of IFN-γ from PHA-stimulated T cells has
been dose dependently inhibited by licochalcone A, extracted
from Chinese liquorice. Similarly another chalcone, naringenin
(60) was investigated against helper T cells (CD4+) sensitized by
OVA and it was observed that this chalcone notably reduced the
secretion of Th2 cytokines i.e., IL-4, IL-5, and IL-13, from mice
splenic CD4T cells (Iwamura et al., 2010). Naringenin, found in
grapefruit and other citrus fruits, significantly abrogated picryl
chloride (PCl)-induced contact hypersensitivity by suppressing
the proliferation and activation of T lymphocytes. The mouse T
cells were activated by anti-CD3 and anti-CD28. In addition, the
aforementioned chalcone also inhibited the mRNA expressions
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of different cytokines, including IL-2, IFN-γ, and TNF-α.
Simultaneously, naringenin also showed T cell apoptosis which
was subjected to the upregulation of Bax, Bad, PARP (poly ADP
ribose polymerase), cleaved-caspase 3 while downregulation of
phosphorylated Akt, Bcl-2 was observed (Fang et al., 2010).
Immunosuppressive Effects of Curcumin
on B Cells
A study conducted by Han et al. (1999) showed that curcumin
exerted antiproliferative effects in a dose-dependent manner
on BKS-2, an immature B cell lymphoma. It was suggested
that curcumin inhibited the proliferation and induced apoptosis
of BKS-2 by inhibiting the activity of NF-κB and further
suppressing the expression of survival and growth genes i.e.,
early growth response protein (egr-1), regulator gene that
codes for transcription factor, (c-myc) Bcl-xL, tumor suppressor
gene p53 (Han et al., 1999). Another study demonstrated that
curcumin was a potent inhibitor of B cell activation and also
associated signaling pathways. It was found that curcumin
treatment demolished proliferation of B cells stimulated by
toll-like receptor ligands LPS and CpG oligodeoxynucleotides.
Furthermore, these inhibitory effects were accounted for the
inhibition of phosphorylation of ERK, Iκ-B, and p38 kinase, NF-
κB activation (Decoté-Ricardo et al., 2009). These observations
indicated the anti-inflammatory effects of curcumin in the B cell
response. Likewise, curcumin exerted immunosuppressive effects
by inhibiting not only LPS induced proliferation of B cells in a
dose-dependent manner but also LPS-induced secretion of IgG1
and IgG2 antibodies. The underlying mechanisms indicated were
the downregulation of CD28 and CD80 expression along with
up-regulation of CTLA-4 (Sharma et al., 2007). Correspondingly,
the inhibitory effects of curcumin on production of IgE
antibodies from rat splenocytes were also evaluated (Kuramoto
et al., 1996).
Interestingly, in one study, curcumin has also been
found to impede the B cell immortalization isolated from
healthy human volunteers and stimulated by Epstein barr
virus (EBV). This process of immortalization led to post-
transplant lymphoproliferative disorders in patient usually on
immunosuppressive drugs like cyclosporine A. However, the
mechanism behind this effect was not explained (McDonald
et al., 1998). Subsequently another study explained that
curcumin regulated the B cell immortalization effect by causing
an increased apoptosis in the B cells infected by EBV (Ranjan
et al., 1999). Curcumin significantly elevated the production
of IgG antibodies from B cells at a higher dose of 40 mg/kg
as compared to lower doses (1, 20 mg/kg) where the antibody
levels were found similar as that of control (South et al., 1997).
Curcumin can also play a crucial role in the treatment of B cell
autoimmune diseases. As evidence from one study, curcumin
has shown concentration-dependent inhibition of activation-
induced cytosine deaminase (AID) expression, an enzyme
regulated by NF-κB and considered important for Ig class switch
recombination and somatic hyper-mutation having a role in
tumorigenesis. This effect was subjected to the demolished
recovery of IgG+ class-switched B cells (Haque et al., 2010).
Immunosuppressive Effects of Curcumin
on Natural Killer Cells
A number of studies have investigated the role of α,β-unsaturated
carbonyl-based compounds on natural killer cell activity against
tumor cells. Earlier studies reported that administration of
different doses of curcumin for duration of 5 weeks exhibited no
effect on NK cell activity (South et al., 1997). Correspondingly,
another study described that in vivo curcumin treatment for
long duration exerted no effect on NK cell activity in ascites
tumor development (Varalakshmi et al., 2008). In contrast,
Yadav et al. (2005) demonstrated that treatment with curcumin
enhanced the in vitro cytotoxicity of NK cells which could be
supplemented by IFN-γ treatment. Lymphokine activated killer
cells (LAK) are analogous to natural killer cells. Gao et al. (2004)
evaluated the production of these non-specific LAK cells induced
by IL-2 in addition to the determination of cytotoxic activity
against YAC-1 lymphoma cells. The results concluded that higher
doses of curcumin significantly reduced LAK cell production. It
was also documented that curcumin treated natural killer cells,
isolated from healthy donors, suppressed the release of IFN-γ and
granzyme B in the presence of K562 and A375 melanoma cell
lines (Bill et al., 2009). Recently, curcumin has also been found
to increase the degradation of tumor derived exosomal proteins
which ultimately inhibited the NK cell activity induced by IL2
against breast carcinoma. These effects of curcumin led to anti-
tumor immune responses (Zhang et al., 2007). Another study
displayed that curcumin exerted cytocidal effects by causing the
cell death of NKL, NK-92, and HANKI (NK/T-cell lymphoma
cell lines) which were not responding to other therapies. This
anti-proliferative activity was subjected to the inhibition of NF-
κB activation in addition to suppression of Bcl-xL, cyclin D1,
XIAP, and c-FLIP expression and the subsequent cleavage and
activation of caspase-8 and poly (ADP-ribose) polymerase (Yadav
et al., 2005). Likewise, the inhibited proliferation of LAK cells was
studied (Mandal and Viswanathan, 2015).
Immunosuppressive Effects of Chalcone
and Its Derivatives on Natural Killer Cells
Flavokawain A chalcone depicted in vivo antitumor activity in
a dose-dependent manner and ultimately inhibiting NK cell
activity in mice via interferon-a synthesis induction (Hornung
et al., 1988).Wleklik et al. (1988) suggested that mice treated with
amentoflavone or quercetin developedmeasurable serum content
of interferon. The antitumor activity of naturally occurring
flavonoids could be attributable to the immunomodulatory
properties of induced interferons with associated augmentation
of NK cell function (Verma et al., 1988). NK cell cytocidal
activity against NK-sensitive K562 and U937 tumor target cells
was accompanied by early increased incorporation of 32P into
PI, suggesting activation of phospholipase C (Steele et al., 1990).
CONCLUSION AND FUTURE PROSPECTS
α, β-Unsaturated carbonyl groups are widely distributed as
reactive substructures of natural compounds and this has
been exemplified by the natural products, curcumin, chalcone,
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and zerumbone. The immunosuppressive effects of these α,β-
unsaturated carbonyl-based compounds and their analogs and
derivatives have been comprehensively studied on neutrophils,
monocytes, and macrophages. These compounds have also been
investigated on other types of immune cells i.e., T cells, B
cells, natural killer cells, and dendritic cells but far less as
compared to neutrophils and macrophages. It is very important
to further explore the biological reactivity of α, β-unsaturated
carbonyl groups, especially on their effects on the immune cells
in different pathological states. The inhibitory effects of the α,
β-unsaturated carbonyl-based compounds on the immune cells
play key role in inflammation. The anti-inflammatory activity
of the compounds were partially mediated by their effects on
the immune cells specifically on inhibition of pro-inflammatory
cytokines expression, NO production, NF-κB activation, and
iNOS. This review may provide useful information for other
scientists to further examine more pharmacological effects of
α, β-unsaturated carbonyl-compounds in different types of
immune cells and hence come up with a promising agent
that may serve as a lead compound for further development
into potent immunomodulating agent in treating different
immune related diseases particularly related to inflammatory
disorders.
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